ANUCORT-HC

Serial Number 97461293
Registration 7161294
700

Registration Progress

Application Filed
Jun 16, 2022
Under Examination
Approved for Publication
Jun 27, 2023
Published for Opposition
Jun 27, 2023
Registered
Sep 12, 2023

Trademark Image

ANUCORT-HC

Basic Information

Serial Number
97461293
Registration Number
7161294
Filing Date
June 16, 2022
Registration Date
September 12, 2023
Published for Opposition
June 27, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 12, 2023
Registration
Registered
Classes
005

Rights Holder

Cosette Pharmaceuticals, Inc.

03
Address
4th Floor
200 Crossing Boulevard
Bridgewater, NJ 08807

Ownership History

Cosette Pharmaceuticals, Inc.

Original Applicant
03
Bridgewater, NJ

Cosette Pharmaceuticals, Inc.

Owner at Publication
03
Bridgewater, NJ

Cosette Pharmaceuticals, Inc.

Original Registrant
03
Bridgewater, NJ

Legal Representation

Attorney
Mark A. Mazza

USPTO Deadlines

Next Deadline
1507 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-09-12)
Due Date
September 12, 2029
Grace Period Ends
March 12, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Oct 16, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 25, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 25, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 25, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 12, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 12, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 27, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 27, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 7, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 22, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 22, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 22, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 22, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
May 22, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 17, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 17, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 17, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 10, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
May 3, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 29, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 29, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 29, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 29, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 30, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 20, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations containing hydrocortisone, namely, rectal suppositories, for inflamed hemorrhoids, post-irradiation factitial proctitis, as an adjunct in the treatment of chronic ulcerative colitis, to treat cryptitis, and to treat other inflammatory conditions of anorectum and pruritus ani
First Use Anywhere: Feb 1, 1992
First Use in Commerce: Feb 1, 1992

Classification

International Classes
005